Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1345379

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1345379

Global Tissue Processing Systems Market - 2023-2030

PUBLISHED:
PAGES: 195 Pages
DELIVERY TIME: 2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4350
PDF & Excel (Multiple User License)
USD 4850
PDF & Excel (Enterprise License)
USD 7850

Add to Cart

Market Overview

Global Tissue Processing Systems Market reached US$ 383.2 million in 2022 and is expected to reach US$ 578.6 million by 2030 growing with a CAGR of 5.4% during the forecast period 2023-2030. The global tissue processing systems market is driven by various factors like an increase in the ageing population, an rise in lifestyle diseases, technological advancements, and rising government initiatives to provide accessible and high-quality healthcare options.

Tissue processing involves transferring fixed animal or human tissue to a microtome for histological wax implantation and section cutting. It involves removing water from cells and replacing it with frozen media for thin slices. After proper repair, the tissue undergoes dehydration, cleansing and infiltration.

Tissue processing in the histology laboratory involves preparing body tissues for disease diagnosis and producing microscopic slides for pathologists to view under a microscope and techniques include biopsies, surgical specimens, and autopsy tissues. Histotechnologists handle tissue processing and glass microscopic slides.

Market Dynamics

Rise in the Prevalence of Cancer Diseases

The rise in the prevalence of cancer is one of the key factors that helps the market to grow during the forecast period. Tissue processing systems are widely used in cancer diagnostic laboratories. Biopsy samples are processed in tissue processors for cancer diagnosis. They can manage a large number of samples, quickly process the samples, and produce high-quality results.

These systems play a crucial role in preparing and processing tissue samples for pathological examination, diagnosis, and research. As the need for accurate and efficient cancer diagnosis and treatment grows, tissue processor systems become essential tools for laboratories and healthcare facilities.

For instance, according to American Cancer Society data, in 2023 there are projected to be 1,958,310 new cancer cases and approximately 609,820 deaths from cancer are expected in the US in 2023 which is about 1,670 deaths per day. Cancer is the second most common cause of death in the US, exceeded only by heart disease.

Rise in Technological Advancements

Tissue processing procedures have been considerably improved in recent years. Tissue processor automation has several advantages, including improved fluid circulation, time savings, and temperature control. Other advantages of automated tissue processors include greatly enhanced tissue processing, automatic cleaning cycles, and reagent management systems. Furthermore, it aids in the reduction of human mistakes. This raises the acceptability of technologically sophisticated tissue processors, hence increasing demand for tissue processing equipment.

Lack of Trained Professionals

The shortage of trained professionals in the tissue processing systems market is due to factors like specialized skill sets, educational programs, and the growing demand for experts in medical research, diagnostics, and biotechnology. The intricate nature of equipment, such as tissue processors, microtomes, and staining machines, further limits the pool of skilled practitioners.

To address this issue, collaboration between academia, industry, and professional organizations is needed, including specialized education, investment in professional development, public awareness, research collaborations, and apprenticeship and internship initiatives.

For more details on this report - Request for Sample

Segment Analysis

The global tissue processing systems market is segmented based on product type, modality, technology, end user and region.

The Small Volume Tissue Processors From The Product Segment Accounted for Approximately 42.1 % of the Tissue Processing Systems Market Share

The small volume of tissue processors from the product segment with around 42.1% is expected to dominate during the forecast period. These are suitable for small laboratory sizes as well as also save space the factors supporting its demand and growth in the market. For instance, the Leica TP1020 semi-enclosed rotary processor is designed for reliability and economy. It can optimize laboratory space with the small footprint of the HistoCore PEARL tissue processor. It is a semi-enclosed benchtop tissue processor with small volumes (≤200 blocks/day).

Geographical Penetration

North America Accounted for Approximately 37.9% of the Market Share in 2022

North America is estimated to hold about 37.9% of the total market share throughout the forecast period, due to the launches of new tissue processors, technological advancements, expansion by key players, growing geriatric population along with adoption of innovative medical technology, rise in cancer incidence, and raising awareness about cancer screening in this region.

For instance, on 3rd February 2022, Leica Biosystems expanded its Dual-Retort Tissue Processor portfolio in North America with HistoCore PEGASUS. The main issue with tissue processing is processing biopsy and large routine specimens in the same run, causing under- or over-processing. In ideal scenarios, biopsy and larger sample tissues should be processed separately using a specific protocol.

Competitive Landscape

The major global players in the tissue processing systems market include JOKOH, Danaher(Leica Biosystems Nussloch GmbH), Medite Medical GmbH, Milestone SRL, Sakura Finetek USA, Inc., SLEE medical GmbH, Bio Optica, Histo-Line Laboratories, General Data Company Inc, Unimeditrek and among others.

COVID-19 Impact Analysis

The COVID-19 pandemic has significantly impacted the histology equipment industry, limiting demand for slide staining and tissue processing systems. Clinical testing providers face logistical challenges such as transportation of tissue samples, access to microscopes, and IT systems. However, companies like Roche Digital Pathology have made decisive steps to overcome these challenges, offering a comprehensive solution for chronic illness diagnosis. This will likely significantly influence the worldwide tissue processing systems market.

Russia Ukraine Conflict Analysis

The Russia-Ukraine war significantly impacted the tissue processing systems market, causing supply chain disruptions and increased raw material costs. Sanctions from several countries cut supply while rising inflation presents new challenges for manufacturers.

By Product Type

  • Small-volume tissue processors
  • Medium Volume tissue processors
  • High Volume tissue processors

By Modality

  • Bench Top tissue processing unit
  • Portable tissue processing unit

By Technology

  • Microwave tissue processors
  • Vaccum tissue processors

By End User

  • Hospitals
  • Academic and Research Institutes
  • Diagnostic Laboratories
  • Others

By Region

  • North America

U.S.

Canada

Mexico

  • Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

  • South America

Brazil

Argentina

Rest of South America

  • Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

  • Middle East and Africa

Key Developments

  • In March 2023, Virscio, a leading provider of translational research and development services, launched a new Pathology and Tissue Pharmacodynamics Division to enhance preclinical drug development programs. The division, led by Dr Jennifer Cann and Richard Bouffard, offers comprehensive non-GLP, GLP, and GCLP histology and pathology services, including tissue processing, slide preparation, staining, immunohistochemistry, digital slide scanning, quantitative image analysis, and pathology interpretation.
  • In September 2022, the histopathology company Sakura Finetek Europe announced the launch of its newest solution Tissue-Tek Genie, an advanced staining system, entering the market.
  • In September 2020, Sakura Finetek USA, Inc. announced the launch of two new laser-printable tissue cassettes, broadening the Tissue-Tek Paraform Sectionable Cassette System for use on the Tissue-Tek AutoTEC a120 Automated Embedding Systems.

Why Purchase the Report?

  • To visualize the global tissue processing systems market segmentation based on product type, modality, technology, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of tissue processing systems market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global tissue processing systems market report would provide approximately 53 tables, 54 figures and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
Product Code: MD6745

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Modality
  • 3.3. Snippet by Technology
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in the Prevalence of Cancer Diseases
      • 4.1.1.2. Rise in Technological Advancements
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of Trained Professionals
    • 4.1.3. Opportunity
      • 4.1.3.1. Rise in Focus on Personalized Medicine
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post Covid-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Small Volume Tissue Processors *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Medium Volume Tissue Processors
  • 7.4. High Volume Tissue Processors

8. By Modality

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 8.1.2. Market Attractiveness Index, By Modality
  • 8.2. Bench Top Tissue Processing Unit*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Portable Tissue Processing Unit

9. By Technology

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.1.2. Market Attractiveness Index, By Technology
  • 9.2. Microwave Tissue Processors *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Vaccum Tissue Processors

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Academic and Research Institutes
  • 10.4. Diagnostic Laboratories
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Spain
      • 11.3.7.5. Italy
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan

Australia

      • 11.5.7.4. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Danaher(Leica Biosystems Nussloch GmbH)*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. JOKOH
  • 13.3. Medite Medical GmbH
  • 13.4. Milestone SRL
  • 13.5. Sakura Finetek USA, Inc.
  • 13.6. SLEE medical GmbH
  • 13.7. Bio Optica
  • 13.8. Histo-Line Laboratories
  • 13.9. General Data Company Inc
  • 13.10. Unimeditrek

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!